Disruption in prepulse inhibition after alpha-1 adrenoceptor stimulation in rats

Neuropharmacology

Volumn 37, Issue 3, 1998, Pages 401-404

  Carasso, Barbara S ^a   Bakshi, Vaishali P ^a   Geyer, Mark A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antipsychotic; Cirazoline; Norepinephrine; Schizophrenia; Sensorimotor gating; Startle

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; CIRAZOLINE; NORADRENALIN; PRAZOSIN; QUETIAPINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; STARTLE REFLEX;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; DIBENZOTHIAZEPINES; DOPAMINE ANTAGONISTS; IMIDAZOLES; MALE; PRAZOSIN; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; SALICYLAMIDES; STARTLE REACTION;

EID: 0032029252     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00051-3     Document Type: Article

References (12)

1. Astrachan D.I., Davis M. Spinal modulation of the acoustic startle response: the role of norepinephrine, serotonin and dopamine. Brain Res. 206:1981;223-228.
2. Bakshi V.P., Swerdlow N.R., Geyer M.A. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J. Pharmacol. Exp. Ther. 279:1994;787-794.
3. Bakshi V.P., Geyer M.A. Phencyclidine-induced deficits in prepulse inhibition are reversed by prazosin, an alpha-1 noradrenergic antagonist. J. Pharmacol. Exp. Ther. 283:1997;666-674.
4. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia: human and animal model studies. Arch. Gen. Psychiatry. 47:1990;181-188.
5. Depoortere R., Perrault G.H., Sanger D.J. Potentation of prepulse inhibition of the startle reflex: pharmacological evaluation of the procedure as a model for detecting antipsychotic activity. Psychopharmacology. 132:1997;366-374.
6. Raulli R.E., Crews F.T. Differences in imidazoline and phenylethylamine alpha-adrenergic agonists: comparison of binding affinity and phosphoinositide response. Neuropharmacology. 30:1991;745-751.
7. Saller C.F., Salama A.I. Seroquel: biochemical profile of a potential atypical antipsychotic. Psychopharmacology. 112:1993;285-292.
8. Snow S.S., Logan T.P., Hollender M.H. Nasal spray 'addiction' and psychosis: a case report. Br. J. Psychiatry. 136:1980;297-299.
9. 2 selective noradrenergic antagonist yohimbine. Biol. Psychiatry. 33:1993;130-132.
10. Swerdlow N.R., Keith V.A., Braff D.L., Geyer M.A. Effects of spiperone, raclopride, SCH23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. J. Pharmacol. Exp. Ther. 256:1991;530-536.
11. Swerdlow N.R., Bakshi V.P., Geyer M.A. Seroquel restores sensorimotor gating in phencyclidine-treated rats. J. Pharmacol. Exp. Ther. 279:1996;1290-1299.
12. van Kammen D.P., Peters J., Yao J., van Kammen W.B., Neylan T., Shaw D., Linnoila M. Norepinephrine in acute exacerbations of chronic schizophrenia. Arch. Gen. Psychiatry. 47:1990;161-168.